Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Synergetics v. Alcon Laboratories

This article was originally published in The Gray Sheet

Executive Summary

Alcon will pay Synergetics $32 million for the right to sell certain Synergetics products on a co-exclusive basis under a licensing deal that also settles all pending litigation between the firms, announced April 27. Other terms were not disclosed. Synergetics had sued Alcon in 2008, accusing Alcon of anti-competitive behavior and alleging that Alcon used its "monopoly power" in the vitrectomy device market to boost sales of surgical illumination devices and related accessories, according to Synergetics' annual report. Alcon then countersued, alleging patent infringement and unfair competition

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT028835

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel